Logo image
Expression of functional pituitary somatostatin receptors in Xenopus oocytes
Journal article   Open access

Expression of functional pituitary somatostatin receptors in Xenopus oocytes

M M White and T Reisine
Proceedings of the National Academy of Sciences - PNAS, v 87(1)
Jan 1990
PMID: 1688651
url
https://doi.org/10.1073/pnas.87.1.133View
Published, Version of Record (VoR) Open

Abstract

Cell Line Protein Biosynthesis Colforsin - pharmacology Xenopus laevis Receptors, Neurotransmitter - genetics Receptors, Neurotransmitter - physiology Somatostatin - pharmacology RNA - genetics Pituitary Neoplasms RNA - isolation & purification Animals Oocytes - physiology Isoproterenol - pharmacology Oocytes - drug effects Female Receptors, Somatostatin Cyclic AMP - metabolism Somatostatin - metabolism Pituitary Gland - physiology
Functional somatostatin (SRIF, somatotropin release-inhibiting factor) receptors were expressed in Xenopus oocytes after injection of RNA isolated from the anterior pituitary tumor cell line AtT20. SRIF receptors were detected by measuring the ability of SRIF to inhibit cAMP formation stimulated by beta 2-adrenergic agonists in individual oocytes. beta 2-Adrenergic receptors (beta 2ARs) were expressed in oocytes by coinjecting RNA prepared by in vitro transcription of a beta 2AR cDNA clone with the pituitary cell RNA. Uninjected oocytes do not express detectable levels of either beta 2ARs or SRIF receptors. In oocytes coinjected with AtT20 and beta 2AR RNA, on the other hand, isoproterenol treatment led to a 2- to 3-fold increase in cAMP levels, whereas cotreatment with SRIF reduced this accumulation by 50-60%. The SRIF precursor somatostatin-28 and the cyclohexapeptide agonist MK678 also inhibited cAMP formation, whereas the biologically inactive N-terminal 14-amino acid fragment of somatostatin-28 was ineffective. The ability to detect changes in cAMP levels in individual oocytes may provide a simple procedure for the expression cloning of SRIF receptor cDNAs and other receptors functionally coupled to stimulation or inhibition of adenylate cyclase.

Metrics

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Biochemistry & Molecular Biology
Logo image